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Abstract
Obsessive-Compulsive Disorder (OCD) affects 2–3% of the worldwide population and can cause 
significant distress and disability to its sufferers. Substantial challenges remain in the field of OCD 
research and therapeutics. Approved interventions only partially alleviate symptoms, with 30–40% 
of patients being resistant to treatment. Research evidence points towards the involvement of 
cortico-striato-thalamocortical circuitry (CSTC) although OCD’s etiology is still unknown. This 
review will focus on the most recent behavior, genetics and neurophysiological findings from 
animal models of OCD. Based on evidence from these models and parallels with human studies, 
we discuss the circuit hyperactivity hypothesis for OCD, a potential circuitry dysfunction of action 
termination, and the involvement of candidate genes. Adding a more biologically-valid framework 
to OCD will help us define and test new hypotheses and facilitate the development of targeted 
therapies based on disease-specific mechanisms.
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Text
Neuropsychiatric disorders encompass a wide range of diseases that manifest as one or many 
altered behaviors, including but not limited to self-injurious behavior, impaired social-
emotional communication and cognitive deficits. Due to the lack of biomarkers and 
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overlapping behavioral symptoms, diagnosis of neuropsychiatric disorders sometimes relies 
on exclusion of other underlying conditions.
Obsessive-Compulsive Disorder (OCD) has a 2–3% worldwide prevalence [1], [2] and is 
characterized by excessive preoccupations (obsessions) associated with specific rituals 
(compulsions). Current treatments to alleviate symptoms include cognitive behavioral 
therapy (CBT) and SSRIs (selective serotonin re-uptake inhibitors) [3], [4]. In cases where 
patients do not respond to CBT and/or medication, other interventions have been used, such 
as deep brain stimulation (DBS) [5]–[7]. Since abnormalities in the glutamatergic system 
have also been proposed in the pathology of OCD, some NMDA receptor antagonists, 
namely ketamine and memantine, are being tested as possible therapies [4], [8].
Previously considered under the spectrum of anxiety disorders, OCD is now categorized 
with other obsessive-compulsive related disorders, including trichotillomania (TTM), body 
dysmorphic disorder, skinpicking, and hoarding disorder, in the recently revised DSM-5 
(Diagnostic and Statistical Manual of Mental Disorders Fifth Edition, 2013). Re-
classification is based on behavioral similarities and common features of these disorders, 
namely obsessive preoccupations and repetitive actions. Such categorization is thought to 
help guide diagnostic criteria and ensure consistency among healthcare providers. However, 
a more “biologically-valid framework” for mental disorders has been proposed by the US 
National Institute of Mental Health (NIMH). This new research framework, designated 
Research Domain Criteria (RDoC), aspires to emphasize mental disorders as biological 
constructs that span specific domains of behavior, emotion, and cognition (e.g., social 
interactions, mood, etc.) that can co-occur in a range from normal to extreme. Future goals 
include using brain mapping, genetic studies, and modeling of cognitive aspects of mental 
disorders to help understand and therapeutically target the biological bases of complex 
neuropsychiatric diseases, including OCD. Animal models can contribute to this 
dimensional approach by providing means to test biological causality.
This review will discuss several areas of research □ neurophysiology, behavior, and 
genetics □ in animal models of compulsive/repetitive behavior that can serve as foundations 
for understanding the basic biology of such behavior.
Neurophysiology of OCD – insights from animal models
- CORTICO-STRIATAL-THALAMO-CORTICAL CIRCUITRY (CSTC)
One of the most replicated findings in human OCD studies is the involvement of cortico-
striatalthalamo-cortical circuitry (CSTC) [9], [10]. Human striatum is anatomically 
subdivided by the internal capsule into caudate nucleus and putamen. Caudate nucleus 
receives mostly excitatory inputs from orbitofrontal, prefrontal and cingulate cortex areas, 
whereas putamen receives the majority of its cortical inputs from sensorimotor areas [11], 
[12]. Increased activity in the anterior cingulate/caudal medial prefrontal cortex, 
orbitofrontal cortex (OFC) and caudate region (areas implicated in some aspects of 
executive function and evaluation of significance [12]) has been reported in OCD [13]. How 
can we connect these findings with behavioral manifestations in OCD? A major advantage 
of studying animal models is the ability to directly manipulate neural circuits and test 
Monteiro and Feng Page 2









behavioral outcomes. Therefore, it is important to define neuroanatomical parallels between 
CSTC structures in humans and mice so that their (dys)function and relevance to OCD can 
be tested (Fig.1).
Based on behavioral studies in mice, a loose definition of limbic, associative and motor 
striatal territories can be adopted, as well as definition of their respective sources of cortical 
inputs [14], [15]. Mouse mPFC seems organized in a dorsal–ventral gradient of connectivity 
such that dorsal-PL projects to dorsomedial regions of striatum (DMS, associative striatum) 
and ventral-PL projects mainly to ventral striatum (limbic striatum)[16]. These ventromedial 
striatum regions are considered to be caudate-like in rodents [15], [17], [18]. Finally, motor 
cortex projects mainly to the mouse dorsolateral striatum (DLS), a region considered similar 
to the primate putamen [15], [17]. It should be emphasized, however, that despite some 
functional resemblance, there are important species-specific differences, with mice lacking 
certain neuroanatomical connectivity possessed by primates (for detailed review please see 
[14]–[17], [19], [20]).
Like the connectivity patterns observed between cortex and striatum, it is believed that 
downstream basal ganglia (BG) territories are equally well-organized into associative, 
limbic and sensorimotor regions. Evidence for this cognitive, emotional and motor 
organization of BG has been made clear through groundbreaking monkey studies [21], [22]. 
Bicuculline injections into limbic regions of globus pallidus (GP) can induce stereotypies, 
whereas injections into associative regions can lead to attention deficit and/or hyperactivity. 
Abnormal movements are not observed unless injections occur within sensorimotor regions 
of GP, suggesting a particular role for associative and limbic territories in the etiology of 
compulsive behaviors [21].
In rats, DLS is known to be required for grooming syntax [23]–[26], a normal physiological 
behavior that appears hyperactive in some OCD-mouse models with self-injurious over-
grooming [27], [28]. Can dysfunction of the rodent putamen-like structure, DLS, and 
seemingly purposeless repetitive routines/stereotypies be related to caudate dysfunction and 
compulsive behaviors in human OCD? Neurophysiology and behavior studies suggest that 
DLS and DMS regions support an important behavioral transition in rodents: intentional 
goal-directed actions, encoded by DMS, that, upon repetition, become habitual automated 
responses, encoded by DLS [16]–[18], [29]–[33]. A dynamic competition is thought to take 
place between these two striatal regions during habit acquisition. DMS activation likely 
guides the expression of behaviors as they transform into habits, but once this DMS activity 
drops, DLS circuits assume control over behaviors [34]. Evidence has emerged from DMS 
lesioned mice that show tendencies for action generalization strategies □ i.e., habitual 
responses □ indicating that DLS guides behavioral performance when DMS function is 
compromised [29]. This might help to explain results from a recent clinical study where a 
deficit in goal-directed control and an overreliance on habits is observed in OCD patients 
[35]. Dysfunctional associative circuitry could hence be affecting the performance of related 
sensorimotor circuits.
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Medium spiny neurons (MSNs) are the major cell type within the striatum and can be 
classified into two main subtypes: striatonigral (D1+ direct-pathway cells; project to SNr) 
and striatopallidal (D2+ indirectpathway cells; project to GP) [36], [37]. The classical model 
of basal ganglia motor output function postulates that direct-pathway activation facilitates 
movement and indirect-pathway activation suppresses movement [38]–[41]. Validity of this 
model has been called into question through recent mouse studies showing concurrent 
activation of both pathways during action initiation [42], while other recent mouse studies 
substantiate the classical model [43]. One possible unifying explanation for these disparate 
results is that activation of both pathways could be important for specific action selection 
and initiation: direct-pathway cells could be activated to promote a specifically intended 
motor program, whereas indirect-pathway cells could be concomitantly activated in order to 
inhibit specific competing motor programs. In this scenario, one could imagine that 
nonspecific activation of all indirect-pathway cells could lead to inhibition of all motor 
programs, as in bradykinesia, whereas overall ablation or silencing of all indirect-pathway 
cells could lead to hyperkinesia.
In addition to MSNs, the striatum contains three main classes of interneurons that regulate 
striatal function: fast-spiking (FS) interneurons that are cytochemically PV+ and project to 
both MSN types but are more likely to target D1+ cells; low-threshold spiking (LTS) 
interneurons; and cholinergic (ChAT+) interneurons [36], [37], [44], [45] (Fig.2). Despite 
their relative sparsity, these interneurons can strongly modulate MSNs, thereby greatly 
influencing final output of the striatum [46]. In fact, in patients with Tourette’s syndrom 
(TS), a disorder often comorbid with OCD, histology of post-mortem striatal tissues 
revealed decreased density of PV+ and ChAT+ interneurons in caudate and putamen regions 
[47], [48]. A potential bridge between TS, OCD, and striatal interneuron dysfunction is also 
suggested by a study, summarized below, where increased MSN activity and lower striatal 
PV+ cell density were observed in a mouse model of OCD [49]. Although interneuron 
dysfunction is a less commonly explored hypothesis in animal models of OCD, it is possible 
that defective interneuron activity might result in or contribute to abnormal striatum 
activation associated with pathology. It will be important to define in future studies exactly 
how these interneuron populations modulate striatum output and how, if at all, they are 
relevant to OCD.
- HYPERACTIVE CIRCUITRY IN OCD
Among the variety of tools that have recently become available to study neural circuits, one 
holds great promise: optogenetics [50], [51]. Using this strategy, a recent study directly 
tested the CSTC hyperactivity hypothesis of OCD [52]. The authors expressed and activated 
ChR2 in mouse medialOFC excitatory neurons that project to ventro-medial striatum. 
Surprisingly, repeated direct hyperactivation of these cells over five consecutive days led to 
a progressive increase in repetitive grooming. Acute stimulation, however, was not 
sufficient to induce increased grooming patterns, suggesting the need for a reinforcing 
circuitry loop in repetitive OCD-like behaviors.
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Another finding in support of the CSTC hyperactivity hypothesis is derived from the Slitrk5-
knockout mouse model. Staining for FosB, a cellular marker of sustained neuronal activity 
[53], showed its levels to be increased specifically at OFC, suggesting hyperactivity of this 
brain region. These results may be particularly relevant to understanding the increased 
metabolic activity observed in OFC and caudate nucleus of OCD patients [54].
A recent study from Thomas Südhof’s lab shows that imbalanced basal ganglia activity can 
clearly influence the formation of repetitive motor routines [55]. In this study, the authors 
showed that disinhibition of direct-pathway MSNs in ventral striatum can enhance the 
formation of repetitive motor routines, observed as increased rotarod learning. Even though 
direct-pathway MSNs in dorsal striatum are important for overall motor coordination, the 
observed phenotype is independent of cerebellum or dorsal striatum. Such studies support 
the idea that different symptom dimensions might be associated with distinct neural 
substrates [56]. Proper balance between direct- and indirect-pathway activity along with 
proper dynamic interaction between different striatal subregions seem crucial for normal 
behavior. Repetitive behaviors observed in OCD may arise from brief but repeated bursts of 
neuronal activity in specific brain areas, facilitating their re-activation by subsequent stimuli.
- A DYSFUNCTION OF TERMINATION (STOP SIGNAL) IN OCD?
CSTC hyperactivity in OCD and consequent propagation of positive-feedback loops could 
emerge from augmented sensitivity to initial triggering stimuli (too much START signal) or 
due to deficiency in motivation to break the initiated behavioral ritual (too little STOP 
signal). Recent work tried to address this question by studying security-related behaviors 
that arise from exposure to contamination cues [57]. Results indicate that the cause of 
patients’ symptoms relies on dysfunctional termination (STOP signal) rather than 
dysfunctional activation (START signal). The root cause of this improper action termination 
may be weakened “motivational satiety”. In line with this hypothesis, a recent report from 
Ann Graybiel’s lab corroborates an insufficiency of the STOP signal and reinforces the 
importance of the OFC-striatal pathway in the genesis of compulsive behaviors [49]. 
Chronic electrophysiological recordings in Sapap3-KO mice, an established model of OCD-
like behaviors (see below), reveal abnormally high spontaneous MSN activity in the 
centromedial striatum, in further support of the hyperexcitability hypothesis. These mice not 
only show deficits in adaptive grooming response during a conditioned grooming task (tone-
delay-water), but also show impaired striatal physiology, where MSNs are incapable of 
adapting and refining their activity during task shaping. These findings point towards 
acquired maladaptive behavior to an initially neutral stimulus. Sapap3-KO mice further 
show reduced striatal FS interneuron density, suggesting that deficient inhibition within 
striatum might contribute to MSN hyperactivity [58]. Interestingly, optogenetic stimulation 
of lOFC somata or afferent terminals in the striatum can successfully alleviate conditioned 
over-grooming as well as naturally occurring compulsive grooming in the Sapap3-KO mice 
[49]. In vivo recording data demonstrates that stimulation of lOFC-striatal pathway increases 
FS-MSN inhibitory efficacy and helps to restore behavioral inhibition, presumably through 
increasing striatal inhibitory tone. Given that FS interneurons synapse onto both MSN 
subtypes but are more likely to target direct-pathway MSNs [45], it is tempting to speculate 
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that the altered feed-forward inhibition of striatal MSNs observed in Sapap3-KO mice more 
profoundly affects the direct-pathway to lead to disinhibition of specific motor compulsions.
Although the aforementioned animal studies from the Hen [52] and Graybiel labs [49] might 
at first appear discrepant □ MO stimulation increases grooming while LO stimulation 
reduces grooming □ it is critical to note that results are derived from different cell 
populations. Importantly, both these studies implicate OFC dysregulation in compulsive 
behaviors and suggest that lateral OFC and medial OFC might be playing different roles in 
OCD, as earlier hypothesized by Rauch, et al [59].
Behavioral studies in OCD-animal models
To evaluate OCD-like behaviors in animal models, specific behavioral paradigms have been 
developed in the last decades to assess multiple factors, such as anxiety and compulsivity. 
Tests of anxiety include open field and elevated zero or plus mazes, where patterns of 
exploratory activity can be evaluated by quantifying time spent in typically anxiogenic open 
areas versus time spent in perimeter or protected areas. Despite the relevance of anxiety in 
OCD, it is important to emphasize that anxiety is an equally relevant trait to other non-OCD 
spectrum disorders. Similarly, it is important to emphasize that OCD itself shares important 
links with other anxiety disorders, although this is not true for all other OC-spectrum 
disorders [60]. Additional behavioral paradigms focus on compulsive behaviors, considering 
them as closer translational manifestations of the human condition. Time spent in repetitive 
tasks, such as non-nutritive chewing, grooming, or shifting/digging in bedding as in the 
marble burying test, can be simply observed. Other more complex tests involve learned tasks 
where presence of compulsive traits can be tested under specific conditioning paradigms. 
The delayed reinforcement task helps to dissociate impulsive choices from the motor 
impulsivity observed in OCD. In addition, reversal learning tasks or serial reaction time 
tasks, in which duration, frequency and perseverance of choices is assessed, can distinguish 
between impulsive and compulsive responses (for detailed reviews, please see [14], [61]).
Animal models of neuropsychiatric disorders should exhibit at least one of the following 
characteristics: atypical behaviors that resemble human symptomatology (face validity); 
shared biological grounds with human conditions, such as mutation of a specific gene 
(construct validity); or successful respose to the same therapeutic agents prescribed to 
patients, allowing outcome predictability (predictive validity). Several animal models 
exhibit OCD-like behaviors and have been useful in underpinning distinct aspects of the 
neurobiology of OCD. The first genetic mouse model presenting face, construct, and 
predictive validity for OCD was published in 2007 [28]. These mice lack SAPAP3, a 
scaffolding protein normally enriched at cortico-striatal glutamatergic synapses. Besides 
impaired cortico-striatal transmission, these mice display self-injurious grooming and 
increased anxiety as assessed by the open field, elevated zero maze and dark light 
emergence tests. Both anxiety and compulsive grooming can be partially alleviated by 
fluoxetine treatment. An interesting key finding is that restoring SAPAP3 expression in the 
striatum alone can rescue self-injurious grooming and cortico-striatal transmission, further 
emphasizing the striatum’s role in compulsive behaviors. A more recent study in this OCD 
mouse model suggests exaggerated stimulus-response habit formation. When mice are 
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conditioned to groom in response to delivery of a water-drop to the forehead preceded by a 
tone, Sapap3-KO mice promptly groom in response to the tone and are unable to re-shape 
this acquired behavior, even when water-drop delivery is subsequently omitted. This 
behavior contrasts sharply with wild-type mice that respond primarily to the water-drop 
rather than the tone, suggesting an abnormal adaptive process to conditioned stimuli in 
OCD.
Other interesting findings have emerged from the deletion of the Slitrk5 gene in mice. 
SLITRK family proteins are involved in neurite outgrowth [62] and absence of SLITRK5 
protein in mice leads to increased anxiety, as assessed by elevated plus-maze and open field 
tests, and compulsivity, as assessed by increased marble burying behavior and self-injurious 
grooming [27]. Chronic fluoxetine treatment can alleviate this phenotype. Thus, Slitrk5-KO 
mice provide researchers with another promising mouse model for studying OCD-like 
behaviors.
Genetic studies of OCD – insights from human patients and animal models
Common acts carried out by OCD patients involve actions such as checking, washing and 
ordering. The fact that these themes are not random and occur consistently in patients across 
distinct socio-cultural backgrounds worldwide raises the possibility of common genetic 
bases [63], [64]. In fact, twin studies of obsessive-compulsive disorder also support this 
prediction, yielding the strongest evidence for genetic contribution in OCD. An extensive 
review work published by van Grootheest, et al. [65] concluded that, using a dimensional 
approach for twin studies, OCD symptoms are highly heritable, ranging from 45–65% in 
childhood-onset OCD and 27–47% in adult-onset OCD.
- SLC1A1/EAAC1
The first genome-wide linkage study for OCD was carried out in 2002 to identify 
susceptible chromosomal regions for early-onset OCD [66]. The results suggest a link to 
chromosomal region 9p24 with the closest gene being SLC1A1 (Solute Carrier Family 1, 
Member 1), a glutamate transporter also known as EAAC1 [67]. Since then, several linkage 
studies have supported OCD association with this genomic region, but with modest cross-
validation, as different studies support different single nucleotide polymorphisms (SNPs) 
associated with the disease [68]–[70]. An EAAC1-KO mouse was first generated and 
published in 1997, albeit with apparently nominal relevance to the study of OCD 
neurobiology and behavior [71]. EAAC1-KO mice develop dicarboxylic aminoaciduria and 
show reduced spontaneous locomotion in the open field. Later studies report reduced 
neuronal glutathione levels and age-dependent neurodegeneration, evidenced by cortical 
thinning and ventricular enlargement [72], [73]. Despite the absence of a strong OCD-like 
phenotype in EAAC1-KO mice, there remain several studies implicating the human EAAC1 
gene in at least some cases of OCD [68], [74]. It is plausible that EAAC-1 functional deficits 
are not well recapitulated in mice or that this gene is involved, rather, in polygenic 
susceptibility to OCD by interacting with other factors.
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- SAPAP AND SLITRK
Recently, an effort has been made to search for common SNPs predisposing individuals to 
OCD. More than twenty research groups have collaborated to accomplish the first Genome-
Wide Association Study (GWAS) for human OCD [75]. Results from this study suggest the 
involvement of two SNPs located within the DLGAP1 gene that encodes the SAPAP1 
protein. Previously, another member from the same family of proteins, SAPAP3, had been 
implicated in the Sapap3-KO mouse model that exhibits OCD-like behavior (see above) 
[28], [76]–[78]. Smaller association studies have supported a role for SAPAP3 in human 
TTM and OCD [79]–[81], reinforcing the idea that proteins from this family might play a 
role in OCD-related behaviors.
Another group, the OCD Collaborative Genetics Association Study (OCGAS) [82], found 
association of a marker on chromosome 9 near the PTPRD gene, although no genome-wide 
significance was achieved. The PTPRD protein seems to play a role in regulating 
development of inhibitory synapses through its interaction with SLITRK3. SLITRKs 
(SLITRK1-6) are a relatively recently discovered family of proteins [62] that have emerged 
as candidate genes in neuropsychiatric disorders [83]. Human genetic studies have suggested 
an association link between SLITRK1 and Tourette’s syndrome, a neuropsychiatric disorder 
characterized by motor and vocal tics [84]. Slitrk1-KO mice display increased anxiety and 
noradrenergic abnormalities [85], consistent with reports of increased norepinephrine levels 
in cerebrospinal fluid of TS patients [86]. The hypothesis of SLITRK1 involvement in TS 
and the fact that SLITRKs are highly expressed in mammalian CNS [87] motivated the 
generation of a Slitrk5-KO mouse to explore possible phenotypes [27]. As described earlier 
in this review, Slitrk5-KO mice display OCD-like behaviors and impaired cortico-striatal 
circuitry. Given that both Slitrk5- and Sapap3-KO mice display impaired cortico-striatal 
transmission and OCD-like behaviors that are responsive to treatment with fluoxetine, one 
of the pharmacological agents used in OCD patients, it would be interesting to address 
whether these mutations of these genes lead to a common defects in molecular pathway or 
circuitry function.
- HOXB8
Another interesting hypothesis concerning OCD etiology comes from genetic deletion of the 
Hoxb8 gene in mice, which suggests a link between the immune system and OCD 
expression [88]. This transcription factor is detected in the adult brain, being expressed in 
bone marrow-derived microglia cells that migrate into the brain’s OFC, cingulate cortex, 
limbic system, and other regions, during the postnatal period [88], [89]. Hoxb8-KO mice 
display self-injurious and cage-mate excessive grooming that can be rescued by bone 
marrow transplantation from wild-type mice. Although this link between the immune system 
and OCD might seem puzzling at first, it has previously been shown that microglia play 
roles in regulating neuronal cell death and in modulating neural networks [90], [91]. In fact, 
a subset of children with OCD can experience worsening of symptoms following 
Streptococcal infection. One brain region that is affected in Pediatric Autoimmune 
Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) is the 
basal ganglia (for recent review on immunobiology of OCD and PANDAS, please see [92]). 
Although expressed brain-wide in the mouse, HOXB8 is predominantly found in adult 
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brainstem, olfactory bulb, cortex and striatum [88], [89], the latter two regions being highly 
implicated in OCD, as discussed earlier.
Although Hoxb8-, Sapap3- and Slitrk5-KO mice have grooming phenotypes that are unique 
in their biological origins, all genes share an enriched cortico-striatal expression. In regards 
to human OCD, these mice studies suggest that a commonly shared pathological behavior, 
compulsivity, may arise from different causal insults that impact the same brain circuits.
- OTHER GENES
Currently approved treatments to alleviate OCD symptoms include medications that 
modulate the serotonergic system. Although the exact mechanisms are unknown, it is 
thought that 5-HT2C serotonin receptor agonism might contribute to therapeutic benefits in 
OCD [93]. Genetic deletion of 5-HT2C-R in mice leads to enhanced sensitivity to induced 
motor stereotypy and compulsive-like behaviors, such as nonnutritive chewing and 
increased head-dipping [94]–[97], supporting a serotonergic involvement in compulsivity. In 
contrast to other OCD models, these mice show less anxiety than wild-type mice in open 
field, elevated plus maze, novel object, and mirrored chamber tests, suggesting that 
compulsivity and anxiety symptoms might be dissociable.
Another useful method to look for candidate genes involved in OCD, besides hypothesis-
driven gene deletion in mice, is genomic sequencing from animals displaying 
spontaneously-occurring pathological behaviors. Some dog breeds display OCD-like 
behaviors, including incessant tail chasing and relentless paw chewing. Given that the dog 
genome is less complex than the human genome, the first canine OCD GWAS study was 
recently carried, identifying four synaptic genes with case-only variations (CDH2, CTNNA2, 
ATXN1, PGCP) [98]. Previous studies in mice have shown that CDH2 gene disruption, 
while being embryonically lethal, causes synaptic dysfunction in cultured neurons [99], 
[100].
Together, the ever-expanding genetic studies of human, mouse, and dog seem to converge 
towards CSTC synaptic dysfunction in OCD pathology (Table 1). Although animal models 
can never fully recapitulate the human OCD spectrum due to species-specific limitations, 
they do allow us to precisely study neurobiological mechanisms of gene-linked phenotypes 
by limiting some of the many confounds inherent to studies of humans, including variability 
in one’s environment and genetic background.
Future perspectives
Much is still to be unraveled in terms of the detailed neurobiology of CSTC circuits in OCD: 
What neuromodulators are imbalanced? Are OCD compulsions dissociable from obsessions 
or anxiety in general? What specific ensemble of neurons encode for compulsions’ motor 
programs? And what brain areas initiate the obsession-compulsion process?
Human functional imaging data seem to suggest hyperactivity in orbito-frontal cortex of 
OCD patients. It is possible that this area could be important for generating specific thoughts 
that in a normal person are easily resolved by performing a particular act, such as double-
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checking something in case of doubt. This behavioral ritual could serve a perfectly banal 
physiological need. However, OCD patients might have insufficient “motivational satiety” 
that prevents resolution and proper termination of the obsession.
To answer the many unresolved questions regarding OCD, continued efforts to understand 
the circuitry involved need to be undertaken, with particular attention to distinct brain 
regions, cell types, and the roles of modulatory neurotransmitters. Some OCD animal 
models discussed in this review point towards specific dysregulations that might be relevant 
as OCD endophenotypes, namely CSTC hyperactivity and dysfunctional task-specific 
behavioral performance, including in adaptive switching to novel stimulus-reinforcement 
associations. Despite the limitations in using animal models to study neuropsychiatric 
disorders, these findings in the evolutionally conserved CSTC circuitry might be of 
relevance across DSM diagnoses and help to guide future translational studies.
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Figure 1. Simplified neuroanatomical model of cortico-striatal circuitry within the human and 
mouse brain
Motor: Human motor cortex is represented here by premotor and sensorimotor cortical 
regions that mainly project to posterolateral putamen [11]. Mouse motor cortex is 
represented here by somatosensory and motor cortex that mainly project to dorso-lateral 
striatum region [16]. Associative: Human associative cortex, represented here by the 
dorsolateral PFC and lateral OFC, projects to the caudate and anteromedial portion of the 
putamen [11]. Mouse associative cortex is represented here by dorsal prelimbic and parietal 
association cortices that mainly project to dorso-medial striatum region [15]. Limbic: 
Human limbic cortex, represented here by the paralimbic and limbic cortices (including 
entorhinal cortexarea28, perirhinal cortex-area35, medial OFC-area11, anterior cingulate 
cortex-area24) [11], [101], projects to the ventral striatum (ventral region of the caudate 
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nucleus and putamen, including nucleus accumbens - NAcc). Mouse limbic cortex is 
represented here by OFC and PFC (ventral prelimbic, infralimbic and cingulate cortices), 
that mainly project to ventromedial striatum region (including NAcc) [15], [16]. Human 
associative and limbic circuits are implicated in stimuli significance and might generate 
obsessive thoughts that cause anxiety. Interconnections with motor cortex and basal ganglia 
circuits then lead to compulsive action execution. Based on the perceived outcome, actions 
can be reinforced and propagated through this repetitive loop. All regions depicted are 
representative and are not intended to provide accurate anatomical locations.
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Figure 2. Representation of intrastriatal microcircuitry
Cortico- and thalamo-striatal excitatory axons target the dendritic spines of MSNs as well as 
dendritic shafts and soma of striatal interneurons. FS interneurons receive more cortical 
contacts and are more responsive to cortical inputs than MSNs [102], [103]; FS interneurons 
synapse proximally onto both MSN types [104] with a bias towards direct-pathway 
D1+MSNs [45]; FS interneurons also synapse with other FS cells but not LTS or TANs 
[45]. LTS interneurons send sparse inhibitory projections onto MSN dendrites [45], [105], 
[106]. TANs send inputs to dendritic spines, shafts and somata of MSNs [107] and provide 
powerful excitatory cholinergic input to FS interneurons [108], [109]. D1+MSNs have more 
elaborate dendritic arbors [110] and their axons project to SNr [37] (not represented); this 
direct-pathway promotes the execution of intended motor programs [42]. D2+MSNs project 
to GP [37] (not represented); this indirect-pathway may inhibit the execution of competing 
motor programs[42]. GPCRs (G protein–coupled receptors) are depicted with their 
associated G-protein: Gs (pink), Gi (brown), Gq (blue). M- muscarinic ACh receptors; 
nAChR- ionotropic nicotinic ACh receptor; D- dopamine receptors; A2A- A2A adenosine 
receptor; ChAT- choline acetyltransferase; Enk- enkephalin; SP- substance P; Dyn- 
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dynorphin; PVparvalbumin; SOM- somatostatin; NPY- neuropeptide Y; NOS- nitric oxide 
synthase.
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